Industries > Pharma > Addiction Treatment Market Report 2021-2031
Addiction Treatment Market Report 2021-2031
Forecasts by Type (Tobacco/ Nicotine, Alcohol dependence, Marijuana, Synthetic Cannabinoids, Prescription and Over-the-Counter Medications, Drug abuse and Others), By Treatment Type (Nicotine Replacement Therapy, Psychological Therapy, Counseling and Behavioral Therapies, Rehabilitation programs, Psychotherapy and Others), By Drug Type (Approved-Drugs and Off-label Drugs), By Product Type (Patch, Gum, Pills, Lozenge, Spray and Others), By Route of Administration (Oral, Inhalation and Injectable), By End-User (Hospitals, Homecare, Specialty Clinics, Rehabilitation Treatment Centers and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others). PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios
Addiction Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the addiction treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 290+ page report provides 500+ tables and 450+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Addiction Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment
Market By Type
• Tobacco/ Nicotine
o Combustible Tobacco
o Smokeless Tobacco
• Alcohol dependence
• Marijuana
• Synthetic Cannabinoids
• Prescription and Over-the-Counter Medications
• Drug Abuse
o Opioid Addiction
o Barbiturate Addiction
o Benzodiazepine Addiction
o Others
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment
Market By Treatment Type
• Nicotine Replacement Therapy
• Psychological Therapy
• Counseling and Behavioral Therapies
• Rehabilitation Programs
• Psychotherapy
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment Market By Drug Type
• Approved-Drugs
o Nicotine
o Varenicline
o Bupropion Hydrochloride
o Methadone
o Disulfiram
o Varenicline
o Acamprosate
o Others
• Off-label Drugs
o Clonidine
o Topiramate
o Naltrexone
o Nortriptyline
o Others
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment Market By Product Type
• Patch
• Gum
• Pills
• Lozenge
• Spray
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment Market By Route of Administration
• Oral
• Inhalation
• Injectable
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment Market By End-User
• Hospitals
• Homecare
• Specialty Clinics
• Rehabilitation Treatment Centers
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Addiction Treatment Market By Distribution Channel
• Hospital Pharmacy
• Retail pharmacy
• Ecommerce
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Addiction Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Addiction Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Addiction Treatment Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Addiction Treatment Market, with forecasts for Get our report today Addiction Treatment Market Forecast 2021-2031: By Type, Treatment Type, Drug Type, Product Type, Route of Administration, End-User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Addiction Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Addiction Treatment Market. Some of the company’s profiled in this report include
• Cipla Ltd.
• GlaxoSmithKline plc
• Pfizer Inc.
• Mallinckrodt Plc.
• Hikma Pharmaceuticals plc
• Orexo AB
• Indivior PLC
• Hager Biosciences, LLC
• ADDEX THERAPEUTICS
• Omeros Corporation
• Sosei Group Corporation
• CV Sciences, Inc
• Astraea Therapeutics LLC
• Johnson & Johnson Services, Inc.
• Novartis AG
• Sanofi
• Dr. Reddy’s Laboratories Ltd
• Teva Pharmaceutical Industries Ltd
• Mylan N.V.
• Axsome Therapeutics, Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Addiction Treatment Market Report 2021-2031: Forecasts by Type (Tobacco/ Nicotine, Alcohol dependence, Marijuana, Synthetic Cannabinoids, Prescription and Over-the-Counter Medications, Drug abuse and Others), By Treatment Type (Nicotine Replacement Therapy, Psychological Therapy, Counseling and Behavioral Therapies, Rehabilitation programs, Psychotherapy and Others), By Drug Type (Approved-Drugs and Off-label Drugs), By Product Type (Patch, Gum, Pills, Lozenge, Spray and Others), By Route of Administration (Oral, Inhalation and Injectable), By End-User (Hospitals, Homecare, Specialty Clinics, Rehabilitation Treatment Centers and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others). PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Addiction Treatment Market
2.1. Addiction Treatment Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Treatment Type Submarkets Definitions
3. Addiction Treatment Market Overview
3.1. Global Addiction Treatment Market Size and Forecast by Region
3.2. Global Addiction Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing consumptions of tobacco products
3.3.1.2. Growing number of FDA approvals coupled with launch of new products
3.3.1.3. Growing demand in emerging economies
3.3.1.4. Increasing government initiatives
3.3.2. Market Restraints
3.3.2.1. Adherence to stringent regulatory norms
3.3.2.2. High cost of development
3.3.2.3. Product recall
3.3.3. Opportunities
3.3.3.1. Government initiative and awareness program
3.3.3.2. Technological advancements and the modernization in addiction treatment
3.3.4. Challenges
3.3.4.1. Increasing number of player in the market
3.3.4.2. Rapid change in logistics and transportation policies
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Addiction Treatment Market Analysis and Forecast 2021-2031, by Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Tobacco/ Nicotine
4.1.1.1. Tobacco/ Nicotine market size and forecast, 2021-2031 (USD Million)
4.1.2. Alcohol dependence
4.1.2.1. Alcohol dependence market size and forecast, 2021-2031 (USD Million)
4.1.3. Marijuana
4.1.3.1. Marijuana market size and forecast, 2021-2031 (USD Million)
4.1.4. Synthetic Cannabinoids
4.1.4.1. Synthetic Cannabinoids market size and forecast, 2021-2031 (USD Million)
4.1.5. Prescription and Over-the-Counter Medications
4.1.5.1. Prescription and Over-the-Counter Medications market size and forecast, 2021-2031 (USD Million)
4.1.6. Drug abuse
4.1.6.1. Drug abuse market size and forecast, 2021-2031 (USD Million)
4.1.7. Others
4.1.7.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Treatment Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Nicotine Replacement Therapy
5.1.1.1. Nicotine Replacement Therapy market size and forecast, 2021-2031 (USD Million)
5.1.2. Psychological Therapy
5.1.2.1. Psychological Therapy market size and forecast, 2021-2031 (USD Million)
5.1.3. Counseling and Behavioral Therapies
5.1.3.1. Counseling and Behavioral Therapies market size and forecast, 2021-2031 (USD Million)
5.1.4. Rehabilitation Programs
5.1.4.1. Rehabilitation Programs market size and forecast, 2021-2031 (USD Million)
5.1.5. Psychotherapy
5.1.5.1. Psychotherapy market size and forecast, 2021-2031 (USD Million)
5.1.6. Others
5.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Approved-Drugs
6.1.1.1. Approved-Drugs market size and forecast, 2021-2031 (USD Million)
6.1.2. Off-label Drugs
6.1.2.1. Off-label Drugs market size and forecast, 2021-2031 (USD Million)
7. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Patch
7.1.1.1. Patch market size and forecast, 2021-2031 (USD Million)
7.1.2. Gum
7.1.2.1. Gum market size and forecast, 2021-2031 (USD Million)
7.1.3. Pills
7.1.3.1. Pills market size and forecast, 2021-2031 (USD Million)
7.1.4. Lozenge
7.1.4.1. Lozenge market size and forecast, 2021-2031 (USD Million)
7.1.5. Spray
7.1.5.1. Spray market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Oral
8.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
8.1.2. Inhalation
8.1.2.1. Inhalation market size and forecast, 2021-2031 (USD Million)
8.1.3. Injectable
8.1.3.1. Injectable market size and forecast, 2021-2031 (USD Million)
9. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals
9.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
9.1.2. Homecare
9.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
9.1.3. Specialty Clinics
9.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
9.1.4. Rehabilitation Treatment Centers
9.1.4.1. Rehabilitation Treatment Centers market size and forecast, 2021-2031 (USD Million)
9.1.5. Others
9.1.5.1. Others market size and forecast, 2021-2031 (USD Million)
10. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.1.1. Hospitals
10.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
10.1.2. Retail Pharmacy
10.1.2.1. Retail Pharmacy Market size and forecast, 2021-2031 (USD Million)
10.1.3. Ecommerce
10.1.3.1. Ecommerce market size and forecast, 2021-2031 (USD Million)
10.1.4. Others
10.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
11. North America Addiction Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. North America Addiction Treatment Market Size and Forecast by Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. North America Addiction Treatment Market Size and Forecast by Treatment Type
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. North America Addiction Treatment Market Size and Forecast by Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. North America Addiction Treatment Market Size and Forecast by Product Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. North America Addiction Treatment Market Size and Forecast by Route of Administration
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. North America Addiction Treatment Market Size and Forecast by End-User
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. North America Addiction Treatment Market Size and Forecast by Distribution Channel
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. U.S. Addiction Treatment Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Canada Addiction Treatment Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Europe Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Europe Addiction Treatment Market Size and Forecast by Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Europe Addiction Treatment Market Size and Forecast by Treatment Type
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Europe Addiction Treatment Market Size and Forecast by Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Europe Addiction Treatment Market Size and Forecast by Product Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Europe Addiction Treatment Market Size and Forecast by Route of Administration
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Europe Addiction Treatment Market Size and Forecast by End-User
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Europe Addiction Treatment Market Size and Forecast by Distribution Channel
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. UK Addiction Treatment Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Germany Addiction Treatment Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. France Addiction Treatment Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
12.12. Rest of Europe Addiction Treatment Market
12.12.1.1. XX Driving/Opportunity Factor
12.12.1.2. XX Driving/Opportunity Factor
13. Asia Pacific Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Asia-Pacific Addiction Treatment Market Size and Forecast by Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Asia-Pacific Addiction Treatment Market Size and Forecast by Treatment Type
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Asia-Pacific Addiction Treatment Market Size and Forecast by Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Asia-Pacific Addiction Treatment Market Size and Forecast by Product Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Asia-Pacific Addiction Treatment Market Size and Forecast by Route of Administration
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Asia-Pacific Addiction Treatment Market Size and Forecast by End-User
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. Asia-Pacific Addiction Treatment Market Size and Forecast by Distribution Channel
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. China Addiction Treatment Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. India Addiction Treatment Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
13.11. Japan Addiction Treatment Market
13.11.1.1. XX Driving/Opportunity Factor
13.11.1.2. XX Driving/Opportunity Factor
13.12. Rest of Asia Pacific Addiction Treatment Market
13.12.1.1. XX Driving/Opportunity Factor
13.12.1.2. XX Driving/Opportunity Factor
14. Latin America Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. Latin America Addiction Treatment Market Size and Forecast by Type
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. Latin America Addiction Treatment Market Size and Forecast by Treatment Type
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. Latin America Addiction Treatment Market Size and Forecast by Drug Type
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. Latin America Addiction Treatment Market Size and Forecast by Product Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. Latin America Addiction Treatment Market Size and Forecast by Route of Administration
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. Latin America Addiction Treatment Market Size and Forecast by End-User
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. Latin America Addiction Treatment Market Size and Forecast by Distribution Channel
14.9. Brazil Addiction Treatment Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Mexico Addiction Treatment Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
14.11. Rest of Latin America Addiction Treatment Market
14.11.1.1. XX Driving/Opportunity Factor
14.11.1.2. XX Driving/Opportunity Factor
15. MEA Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
15.1. Market Overview
15.2. MEA Addiction Treatment Market Size and Forecast by Type
15.2.1.1. XX Driving/Opportunity Factor
15.2.1.2. XX Driving/Opportunity Factor
15.3. MEA Addiction Treatment Market Size and Forecast by Treatment Type
15.3.1.1. XX Driving/Opportunity Factor
15.3.1.2. XX Driving/Opportunity Factor
15.4. MEA Addiction Treatment Market Size and Forecast by Drug Type
15.4.1.1. XX Driving/Opportunity Factor
15.4.1.2. XX Driving/Opportunity Factor
15.5. MEA Addiction Treatment Market Size and Forecast by Product Type
15.5.1.1. XX Driving/Opportunity Factor
15.5.1.2. XX Driving/Opportunity Factor
15.6. MEA Addiction Treatment Market Size and Forecast by Route of Administration
15.6.1.1. XX Driving/Opportunity Factor
15.6.1.2. XX Driving/Opportunity Factor
15.7. MEA Addiction Treatment Market Size and Forecast by End-User
15.7.1.1. XX Driving/Opportunity Factor
15.7.1.2. XX Driving/Opportunity Factor
15.8. MEA Addiction Treatment Market Size and Forecast by Distribution Channel
15.8.1.1. XX Driving/Opportunity Factor
15.8.1.2. XX Driving/Opportunity Factor
15.9. GCC Addiction Treatment Market
15.9.1.1. XX Driving/Opportunity Factor
15.9.1.2. XX Driving/Opportunity Factor
15.10. South Africa Addiction Treatment Market
15.10.1.1. XX Driving/Opportunity Factor
15.10.1.2. XX Driving/Opportunity Factor
15.11. Rest of MEA Addiction Treatment Market
15.11.1.1. XX Driving/Opportunity Factor
15.11.1.2. XX Driving/Opportunity Factor
16. Companies in the Addiction Treatment Market
16.1. Cipla Ltd.
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Performance (2015-2019)
16.1.3.1. Net Revenue
16.1.3.2. Gross Profit
16.1.3.3. Geographical Revenue, 2019
16.1.4. Product Offerings
16.1.5. Recent Initiatives (2017-2019)
16.2. GlaxoSmithKline plc
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Performance (2015-2019)
16.2.3.1. Net Revenue
16.2.3.2. Gross Profit
16.2.3.3. Geographical Revenue, 2019
16.2.4. Product Offerings
16.2.5. Recent Initiatives (2017-2019)
16.3. Pfizer Inc.
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Performance (2015-2019)
16.3.3.1. Net Revenue
16.3.3.2. Gross Profit
16.3.3.3. Geographical Revenue, 2019
16.3.4. Product Offerings
16.3.5. Recent Initiatives (2017-2019)
16.4. Mallinckrodt Plc.
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Performance (2015-2019)
16.4.3.1. Net Revenue
16.4.3.2. Gross Profit
16.4.3.3. Geographical Revenue, 2019
16.4.4. Product Offerings
16.4.5. Recent Initiatives (2017-2019)
16.5. Hikma Pharmaceuticals plc
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Performance (2015-2019)
16.5.3.1. Net Revenue
16.5.3.2. Gross Profit
16.5.3.3. Geographical Revenue, 2019
16.5.4. Product Offerings
16.5.5. Recent Initiatives (2017-2019)
16.6. Orexo AB
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Performance (2015-2019)
16.6.3.1. Net Revenue
16.6.3.2. Gross Profit
16.6.3.3. Geographical Revenue, 2019
16.6.4. Product Offerings
16.6.5. Recent Initiatives (2017-2019)
16.7. Indivior PLC
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Performance (2015-2019)
16.7.3.1. Net Revenue
16.7.3.2. Gross Profit
16.7.3.3. Geographical Revenue, 2019
16.7.4. Product Offerings
16.7.5. Recent Initiatives (2017-2019)
16.8. Hager Biosciences, LLC
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Performance (2015-2019)
16.8.3.1. Net Revenue
16.8.3.2. Gross Profit
16.8.3.3. Geographical Revenue, 2019
16.8.4. Product Offerings
16.8.5. Recent Initiatives (2017-2019)
16.9. ADDEX THERAPEUTICS
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Performance (2015-2019)
16.9.3.1. Net Revenue
16.9.3.2. Gross Profit
16.9.3.3. Geographical Revenue, 2019
16.9.4. Product Offerings
16.9.5. Recent Initiatives (2017-2019)
16.10. Omeros Corporation
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Performance (2015-2019)
16.10.3.1. Net Revenue
16.10.3.2. Gross Profit
16.10.3.3. Geographical Revenue, 2019
16.10.4. Product Offerings
16.10.5. Recent Initiatives (2017-2019)
16.11. Sosei Group Corporation
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financial Performance (2015-2019)
16.11.3.1. Net Revenue
16.11.3.2. Gross Profit
16.11.3.3. Geographical Revenue, 2019
16.11.4. Product Offerings
16.11.5. Recent Initiatives (2017-2019)
16.12. CV Sciences, Inc
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financial Performance (2015-2019)
16.12.3.1. Net Revenue
16.12.3.2. Gross Profit
16.12.3.3. Geographical Revenue, 2019
16.12.4. Product Offerings
16.12.5. Recent Initiatives (2017-2019)
16.13. Astraea Therapeutics LLC
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financial Performance (2015-2019)
16.13.3.1. Net Revenue
16.13.3.2. Gross Profit
16.13.3.3. Geographical Revenue, 2019
16.13.4. Product Offerings
16.13.5. Recent Initiatives (2017-2019)
16.14. Johnson & Johnson Services, Inc.
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financial Performance (2015-2019)
16.14.3.1. Net Revenue
16.14.3.2. Gross Profit
16.14.3.3. Geographical Revenue, 2019
16.14.4. Product Offerings
16.14.5. Recent Initiatives (2017-2019)
16.15. Novartis AG
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financial Performance (2015-2019)
16.15.3.1. Net Revenue
16.15.3.2. Gross Profit
16.15.3.3. Geographical Revenue, 2019
16.15.4. Product Offerings
16.15.5. Recent Initiatives (2017-2019)
16.16. Sanofi
16.16.1. Company Snapshot
16.16.2. Company Overview
16.16.3. Financial Performance (2015-2019)
16.16.3.1. Net Revenue
16.16.3.2. Gross Profit
16.16.3.3. Geographical Revenue, 2019
16.16.4. Product Offerings
16.16.5. Recent Initiatives (2017-2019)
16.17. Dr. Reddy’s Laboratories Ltd
16.17.1. Company Snapshot
16.17.2. Company Overview
16.17.3. Financial Performance (2015-2019)
16.17.3.1. Net Revenue
16.17.3.2. Gross Profit
16.17.3.3. Geographical Revenue, 2019
16.17.4. Product Offerings
16.17.5. Recent Initiatives (2017-2019)
16.18. Teva Pharmaceutical Industries Ltd
16.18.1. Company Snapshot
16.18.2. Company Overview
16.18.3. Financial Performance (2015-2019)
16.18.3.1. Net Revenue
16.18.3.2. Gross Profit
16.18.3.3. Geographical Revenue, 2019
16.18.4. Product Offerings
16.18.5. Recent Initiatives (2017-2019)
16.19. Mylan N.V.
16.19.1. Company Snapshot
16.19.2. Company Overview
16.19.3. Financial Performance (2015-2019)
16.19.3.1. Net Revenue
16.19.3.2. Gross Profit
16.19.3.3. Geographical Revenue, 2019
16.19.4. Product Offerings
16.19.5. Recent Initiatives (2017-2019)
16.20. Axsome Therapeutics, Inc.
16.20.1. Company Snapshot
16.20.2. Company Overview
16.20.3. Financial Performance (2015-2019)
16.20.3.1. Net Revenue
16.20.3.2. Gross Profit
16.20.3.3. Geographical Revenue, 2019
16.20.4. Product Offerings
16.20.5. Recent Initiatives (2017-2019)
16.21. Other Notable Players
17. Conclusion
18. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Addiction Treatment Market Drivers & Restraints 2021
Table 7. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Amplifier Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 54. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 59. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 60. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 61. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 62. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 63. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 64. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 69. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 73. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 74. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 75. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 76. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 77. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 109. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 114. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 119. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 123. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 124. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 125. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 126. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 127. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 133.
Table 134. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 135. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 136. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 137. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 138. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 139. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 140. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 141. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 142. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 143. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 144. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 145. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 146. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 147. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 148. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 149. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 150. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 151. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 152. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 153. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 154. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 155. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 156. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 157. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 158. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 159. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 160. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 161. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 162. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 163. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 164. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 165. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 166. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 167. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 168. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 169. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 170. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 171. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 172. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 173. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 174. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 175. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 176. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 177. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 178. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 179. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 180. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 181. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 182. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 183. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 184. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 185. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 186. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 187. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 188. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 189. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 190. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 191. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 192. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 193. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 194. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 195. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 196. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 197. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 198. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 199. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 200. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 201. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 202. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 203. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 204. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 205. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 206. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 207. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 208. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 209. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 210. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 211. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 212. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 213. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 214. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 215. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 216. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 217. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 218. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 219. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 220. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 221. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 222. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 223. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 224. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 225. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 226. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 227. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 228. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 229. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 230. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 231. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 232. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 233. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 234. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 235. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 236. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 237. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 238. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 239. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 240. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 241. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 242. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 243. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 244. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 245. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 246. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 247. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 248. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 249. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 250. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 251. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 252. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 253. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 254. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 255. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 256. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 257. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 258. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 259. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 260. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 261. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 262. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 263. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 264. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 265. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 266. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 267. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 268. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 269. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 270. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 271. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 272. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 273. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 274. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 275. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 276. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 277. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 278. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 279. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 280. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 281. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 282. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 283. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 284. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 285. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 286. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 287. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 288. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 289. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 290. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 291. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 292. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 293. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 294. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 295. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 296. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 297. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 298. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 299. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 300. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 301. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 302. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 303. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 304. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 305. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 306. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 307. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 308. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 309. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 310. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 311. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 312. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 313. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 314. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 315. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 316. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 317. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 318. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 319. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 320. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 321. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 322. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 323. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 324. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 325. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 326. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 327. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 328. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 329. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 330. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 331. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 332. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 333. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 334. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 335. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 336. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 337. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 338. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 339. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 340. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 341. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 342. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 343. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 344. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 345. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 346. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 347. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 348. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 349. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 350. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 351. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 352. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 353. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 354. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 355. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 356. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 357. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 358. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 359. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 360. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 361. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 362. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 363. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 364. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 365. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 366. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 367. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 368. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 369. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 370. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 371. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 372. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 373. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 374. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 375. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 376. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 377. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 378. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 379. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 380. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 381. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 382. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 383. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 384. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 385. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 386. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 387. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 388. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 389. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 390. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 391. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 392. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 393. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 394. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 395. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 396. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 397. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 398. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 399. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 400. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 401. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 402. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 403. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 404. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 405. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 406. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 407. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 408. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 409. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 410. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 411. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 412. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 413. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 414. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 415. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 416. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 417. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 418. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 419. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 420. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 421. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 422. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 423. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 424. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 425. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 426. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 427. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 428. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 429. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 430. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 431. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 432. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 433. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 434. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 435. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 436. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 437. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 438. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 439. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 440. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 441. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 442. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 443. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 444. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 445. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 446. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 447. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 448. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 449. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 450. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 451. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 452. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 453. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 454. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 455. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 456. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 457. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 458. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 459. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 460. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 461. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 462. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 463. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 464. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 465. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 466. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 467. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 468. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 469. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 470. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 471. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 472. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 473. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 474. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 475. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 476. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 477. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 478. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 479. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 480. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 481. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 482. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 483. Leading 20 Addiction Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 484. Cipla Ltd.Profile 2019 (CEO, HQ, Founded, Website)
Table 485. Cipla Ltd. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 486. GlaxoSmithKline plc Profile 2019 (CEO, HQ, Founded, Website)
Table 487. GlaxoSmithKline plc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 488. Pfizer Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 489. Mallinckrodt Plc.Addiction Treatment Product Offering (Segment, Product Offerings)
Table 490. Hikma Pharmaceuticals plc Profile 2019 (CEO, HQ, Founded, Website)
Table 491. Hikma Pharmaceuticals plc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 492. Orexo AB Profile 2019 (CEO, HQ, Founded, Website)
Table 493. Orexo AB Addiction Treatment Product Offering (Segment, Product Offerings)
Table 494. Indivior PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 495. Indivior PLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 496. Hager Biosciences, LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 497. Hager Biosciences, LLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 498. ADDEX THERAPEUTICS Profile 2019 (CEO, HQ, Founded, Website)
Table 499. ADDEX THERAPEUTICS Addiction Treatment Product Offering (Segment, Product Offerings)
Table 500. Omeros Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 501. Omeros Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 502. Sosei Group Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 503. Sosei Group Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 504. CV Sciences, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 505. CV Sciences, Inc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 506. Astraea Therapeutics LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 507. Astraea Therapeutics LLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 508. Johnson & Johnson Services, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 509. Johnson & Johnson Services, Inc. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 510. Novartis AG Profile 2019 (CEO, HQ, Founded, Website)
Table 511. Novartis AG Addiction Treatment Product Offering (Segment, Product Offerings)
Table 512. Sanofi Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 513. Sanofi Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 514. Dr. Reddy’s Laboratories Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 515. Dr. Reddy’s Laboratories Ltd Addiction Treatment Product Offering (Segment, Product Offerings)
Table 516. Teva Pharmaceutical Industries Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 517. Teva Pharmaceutical Industries Ltd Addiction Treatment Product Offering (Segment, Product Offerings)
Table 518. Mylan N.V.Profile 2019 (CEO, HQ, Founded, Website)
Table 519. Mylan N.V.Addiction Treatment Product Offering (Segment, Product Offerings)
Table 520. Axsome Therapeutics, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 521. Axsome Therapeutics, Inc. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 522. Other Companies Involved in the Addiction Treatment Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Addiction Treatment Market Application Overview
Figure 2. Addiction Treatment Market Component Overview
Figure 3. Addiction Treatment Market Treatment Type Overview
Figure 4. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 35. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 36. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 37. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 38. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 39. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49. Amplifier Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 56. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 57. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 58. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 59. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 60. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 61. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 62. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 63. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 64. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 65. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 66. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 67. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 68. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 69. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 70. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 71. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 72. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 73. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 74. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 75. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 76. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 77. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 78. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 79. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 82. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 85. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 86. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 87. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 88. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 89. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 90. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 91. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 92. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 93. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 94. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 95. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 96. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 97. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 98. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 99. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 100. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 101. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 102. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 103. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 104. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 105. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 106. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 107. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 108. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 109. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 110. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 111. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 112. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 113. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 114. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 115. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 116. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 117. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 118. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 119. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 120. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 121. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 122. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 123. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 124. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 125. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 126. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 127. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 128. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 129. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 132. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 133. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 134. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 135.
Figure 136. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 137. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 138. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 139. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 140. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 141. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 142. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 143. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 144. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 145. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 146. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 147. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 148. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 149. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 150. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 151. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 152. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 153. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 154. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 155. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 156. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 157. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 158. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 159. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 160. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 161. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 162. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 163. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 164. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 165. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 166. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 167. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 168. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 169. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 170. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 171. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 172. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 173. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 174. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 175. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 176. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 177. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 178. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 179. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 180. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 181. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 182. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 187. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 192. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 197. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 202. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 207. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 212. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 213. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 214. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 215. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 216. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 217. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 218. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 219. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 220. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 221. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 222. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 223. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 224. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 225. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 226. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 227. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 228. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 229. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 230. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 231. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 232. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 233. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 234. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 235. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 236. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 237. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 238. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 239. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 240. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 241. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 242. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 243. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 244. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 245. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 246. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 247. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 248. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 249. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 250. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 251. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 252. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 253. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 254. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 255. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 256. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 257. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 258. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 259. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 260. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 261. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID) Table 82.
Figure 262. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 263. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 264. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 265. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 266. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 267. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 268. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 269. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 270. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 271. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 272. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 273. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 274. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 275. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 276. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 277. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 278. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 279. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 280. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 281. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 282. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 283. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 284. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 285. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 286. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 287. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 288. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 289. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 290. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 291. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 292. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 293. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 294. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 295. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 296. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 297. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 298. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 299. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 300. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 301. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 302. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 303. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 304. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 305. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 306. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 307. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 308. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 309. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 310. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 311. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 312. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 313. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 314. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 315. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 316. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 317. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 318. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 319. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 320. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 321. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 322. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 323. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 324. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 325. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 326. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 327. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 328. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 329. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 330. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 331. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 332. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 333. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 334. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 335. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 336. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 337. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 338. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 339. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 340. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 341. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 342. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 343. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 344. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 345. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 346. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 347. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 348. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 349. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 350. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 351. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 352. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 353. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 354. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 355. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 356. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 357. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 358. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 359. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 360. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 361. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 362. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 363. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 364. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 365. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 366. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 367. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 368. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 369. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 370. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 371. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 372. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 373. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 374. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 375. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 376. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 377. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 378. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 379. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 380. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 381. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 382. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 383. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 384. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 385. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 386. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 387. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 388. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 389. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 390. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 391. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 392. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 393. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 394. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 395. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 396. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 397. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 398. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 399. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 400. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 401. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 402. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 403. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 404. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 405. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 406. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 407. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 408. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 409. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 410. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 411. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 412. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 413. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 414. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 415. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 416. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 417. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 418. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 419. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 420. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 421. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 422. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 423. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 424. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 425. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 426. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 427. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 428. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 429. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 430. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 431. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 432. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 433. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 434. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 435. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 436. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 437. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 438. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 439. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 440. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 441. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 442. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 443. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 444. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 445. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 446. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 447. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 448. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 449. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 450. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 451. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 452. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 453. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 454. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 455. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 456. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 457. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 458. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 459. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 460. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 461. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 462. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 463. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 464. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 465. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 466. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 467. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 468. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 469. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 470. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 471. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 472. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 473. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 474. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 475. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 476. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 477. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 478. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 479. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 480. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 481. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 482. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 483. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 484. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 485. Porter’s Five Force Analysis
Companies Mentioned
1. Cipla Ltd.
2. GlaxoSmithKline plc
3. Pfizer Inc.
4. Mallinckrodt Plc.
5. Hikma Pharmaceuticals plc
6. Orexo AB
7. Indivior PLC
8. Hager Biosciences, LLC
9. ADDEX THERAPEUTICS
10. Omeros Corporation
11. Sosei Group Corporation
12. CV Sciences, Inc
13. Astraea Therapeutics LLC
14. Johnson & Johnson Services, Inc.
15. Novartis AG
16. Sanofi
17. Dr. Reddy’s Laboratories Ltd
18. Teva Pharmaceutical Industries Ltd
19. Mylan N.V.
20. Axsome Therapeutics, Inc.
21. Hager Biosciences, LLC
22. Axsome Therapeutics, Inc.
23. Cerecor, Inc
24. Axsome Therapeutics, Inc
25. H. Lundbeck A/S
26. Zydus Cadila
27. Glenmark Pharmaceuticals Ltd
28. Alvogen
29. Sigmapharm Laboratories, LLC
30. Bausch Health
31. Currax Pharmaceuticals LLC
32. Alkermes
33. Mallinckrodt plc
34. Teva Pharmaceutical Industries Ltd
35. Pharmaceutical Associates Inc,
36. Reckitt Benckiser (Indivior PLC)
37. Alkermes PLC
38. Allergan, Plc
39. Celtic Pharma Holdings Advisors LLP
40. Cipla Limited
41. Consern Pharma Private Limited
42. Eli Lilly and Company
43. GlaxoSmithKline plc (GSK)
44. Intas Biopharmaceuticals
45. Johnson & Johnson
46. Mallinckrodt Pharmaceuticals
47. Medtronic
48. Novartis International AG
49. Orasure Technologies
50. PSYCHEMEDICS CORPORATION
51. Purdue Pharma L.P.
52. Reckitt Benckiser Group plc
53. Sun Pharmaceutical Industries Limited
54. Takeda Pharmaceutical Company Ltd
55. TEVA PHARMACEUTICALS INDUSTRIES LIMITED
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Addiction Treatment Market
2.1. Addiction Treatment Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Treatment Type Submarkets Definitions
3. Addiction Treatment Market Overview
3.1. Global Addiction Treatment Market Size and Forecast by Region
3.2. Global Addiction Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing consumptions of tobacco products
3.3.1.2. Growing number of FDA approvals coupled with launch of new products
3.3.1.3. Growing demand in emerging economies
3.3.1.4. Increasing government initiatives
3.3.2. Market Restraints
3.3.2.1. Adherence to stringent regulatory norms
3.3.2.2. High cost of development
3.3.2.3. Product recall
3.3.3. Opportunities
3.3.3.1. Government initiative and awareness program
3.3.3.2. Technological advancements and the modernization in addiction treatment
3.3.4. Challenges
3.3.4.1. Increasing number of player in the market
3.3.4.2. Rapid change in logistics and transportation policies
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Addiction Treatment Market Analysis and Forecast 2021-2031, by Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Tobacco/ Nicotine
4.1.1.1. Tobacco/ Nicotine market size and forecast, 2021-2031 (USD Million)
4.1.2. Alcohol dependence
4.1.2.1. Alcohol dependence market size and forecast, 2021-2031 (USD Million)
4.1.3. Marijuana
4.1.3.1. Marijuana market size and forecast, 2021-2031 (USD Million)
4.1.4. Synthetic Cannabinoids
4.1.4.1. Synthetic Cannabinoids market size and forecast, 2021-2031 (USD Million)
4.1.5. Prescription and Over-the-Counter Medications
4.1.5.1. Prescription and Over-the-Counter Medications market size and forecast, 2021-2031 (USD Million)
4.1.6. Drug abuse
4.1.6.1. Drug abuse market size and forecast, 2021-2031 (USD Million)
4.1.7. Others
4.1.7.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Treatment Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Nicotine Replacement Therapy
5.1.1.1. Nicotine Replacement Therapy market size and forecast, 2021-2031 (USD Million)
5.1.2. Psychological Therapy
5.1.2.1. Psychological Therapy market size and forecast, 2021-2031 (USD Million)
5.1.3. Counseling and Behavioral Therapies
5.1.3.1. Counseling and Behavioral Therapies market size and forecast, 2021-2031 (USD Million)
5.1.4. Rehabilitation Programs
5.1.4.1. Rehabilitation Programs market size and forecast, 2021-2031 (USD Million)
5.1.5. Psychotherapy
5.1.5.1. Psychotherapy market size and forecast, 2021-2031 (USD Million)
5.1.6. Others
5.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Approved-Drugs
6.1.1.1. Approved-Drugs market size and forecast, 2021-2031 (USD Million)
6.1.2. Off-label Drugs
6.1.2.1. Off-label Drugs market size and forecast, 2021-2031 (USD Million)
7. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Patch
7.1.1.1. Patch market size and forecast, 2021-2031 (USD Million)
7.1.2. Gum
7.1.2.1. Gum market size and forecast, 2021-2031 (USD Million)
7.1.3. Pills
7.1.3.1. Pills market size and forecast, 2021-2031 (USD Million)
7.1.4. Lozenge
7.1.4.1. Lozenge market size and forecast, 2021-2031 (USD Million)
7.1.5. Spray
7.1.5.1. Spray market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Oral
8.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
8.1.2. Inhalation
8.1.2.1. Inhalation market size and forecast, 2021-2031 (USD Million)
8.1.3. Injectable
8.1.3.1. Injectable market size and forecast, 2021-2031 (USD Million)
9. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals
9.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
9.1.2. Homecare
9.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
9.1.3. Specialty Clinics
9.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
9.1.4. Rehabilitation Treatment Centers
9.1.4.1. Rehabilitation Treatment Centers market size and forecast, 2021-2031 (USD Million)
9.1.5. Others
9.1.5.1. Others market size and forecast, 2021-2031 (USD Million)
10. Global Addiction Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.1.1. Hospitals
10.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
10.1.2. Retail Pharmacy
10.1.2.1. Retail Pharmacy Market size and forecast, 2021-2031 (USD Million)
10.1.3. Ecommerce
10.1.3.1. Ecommerce market size and forecast, 2021-2031 (USD Million)
10.1.4. Others
10.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
11. North America Addiction Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. North America Addiction Treatment Market Size and Forecast by Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. North America Addiction Treatment Market Size and Forecast by Treatment Type
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. North America Addiction Treatment Market Size and Forecast by Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. North America Addiction Treatment Market Size and Forecast by Product Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. North America Addiction Treatment Market Size and Forecast by Route of Administration
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. North America Addiction Treatment Market Size and Forecast by End-User
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. North America Addiction Treatment Market Size and Forecast by Distribution Channel
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. U.S. Addiction Treatment Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Canada Addiction Treatment Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Europe Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Europe Addiction Treatment Market Size and Forecast by Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Europe Addiction Treatment Market Size and Forecast by Treatment Type
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Europe Addiction Treatment Market Size and Forecast by Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Europe Addiction Treatment Market Size and Forecast by Product Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Europe Addiction Treatment Market Size and Forecast by Route of Administration
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Europe Addiction Treatment Market Size and Forecast by End-User
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Europe Addiction Treatment Market Size and Forecast by Distribution Channel
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. UK Addiction Treatment Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Germany Addiction Treatment Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. France Addiction Treatment Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
12.12. Rest of Europe Addiction Treatment Market
12.12.1.1. XX Driving/Opportunity Factor
12.12.1.2. XX Driving/Opportunity Factor
13. Asia Pacific Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Asia-Pacific Addiction Treatment Market Size and Forecast by Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Asia-Pacific Addiction Treatment Market Size and Forecast by Treatment Type
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Asia-Pacific Addiction Treatment Market Size and Forecast by Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Asia-Pacific Addiction Treatment Market Size and Forecast by Product Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Asia-Pacific Addiction Treatment Market Size and Forecast by Route of Administration
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Asia-Pacific Addiction Treatment Market Size and Forecast by End-User
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. Asia-Pacific Addiction Treatment Market Size and Forecast by Distribution Channel
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. China Addiction Treatment Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. India Addiction Treatment Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
13.11. Japan Addiction Treatment Market
13.11.1.1. XX Driving/Opportunity Factor
13.11.1.2. XX Driving/Opportunity Factor
13.12. Rest of Asia Pacific Addiction Treatment Market
13.12.1.1. XX Driving/Opportunity Factor
13.12.1.2. XX Driving/Opportunity Factor
14. Latin America Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. Latin America Addiction Treatment Market Size and Forecast by Type
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. Latin America Addiction Treatment Market Size and Forecast by Treatment Type
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. Latin America Addiction Treatment Market Size and Forecast by Drug Type
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. Latin America Addiction Treatment Market Size and Forecast by Product Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. Latin America Addiction Treatment Market Size and Forecast by Route of Administration
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. Latin America Addiction Treatment Market Size and Forecast by End-User
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. Latin America Addiction Treatment Market Size and Forecast by Distribution Channel
14.9. Brazil Addiction Treatment Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Mexico Addiction Treatment Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
14.11. Rest of Latin America Addiction Treatment Market
14.11.1.1. XX Driving/Opportunity Factor
14.11.1.2. XX Driving/Opportunity Factor
15. MEA Addiction Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
15.1. Market Overview
15.2. MEA Addiction Treatment Market Size and Forecast by Type
15.2.1.1. XX Driving/Opportunity Factor
15.2.1.2. XX Driving/Opportunity Factor
15.3. MEA Addiction Treatment Market Size and Forecast by Treatment Type
15.3.1.1. XX Driving/Opportunity Factor
15.3.1.2. XX Driving/Opportunity Factor
15.4. MEA Addiction Treatment Market Size and Forecast by Drug Type
15.4.1.1. XX Driving/Opportunity Factor
15.4.1.2. XX Driving/Opportunity Factor
15.5. MEA Addiction Treatment Market Size and Forecast by Product Type
15.5.1.1. XX Driving/Opportunity Factor
15.5.1.2. XX Driving/Opportunity Factor
15.6. MEA Addiction Treatment Market Size and Forecast by Route of Administration
15.6.1.1. XX Driving/Opportunity Factor
15.6.1.2. XX Driving/Opportunity Factor
15.7. MEA Addiction Treatment Market Size and Forecast by End-User
15.7.1.1. XX Driving/Opportunity Factor
15.7.1.2. XX Driving/Opportunity Factor
15.8. MEA Addiction Treatment Market Size and Forecast by Distribution Channel
15.8.1.1. XX Driving/Opportunity Factor
15.8.1.2. XX Driving/Opportunity Factor
15.9. GCC Addiction Treatment Market
15.9.1.1. XX Driving/Opportunity Factor
15.9.1.2. XX Driving/Opportunity Factor
15.10. South Africa Addiction Treatment Market
15.10.1.1. XX Driving/Opportunity Factor
15.10.1.2. XX Driving/Opportunity Factor
15.11. Rest of MEA Addiction Treatment Market
15.11.1.1. XX Driving/Opportunity Factor
15.11.1.2. XX Driving/Opportunity Factor
16. Companies in the Addiction Treatment Market
16.1. Cipla Ltd.
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Performance (2015-2019)
16.1.3.1. Net Revenue
16.1.3.2. Gross Profit
16.1.3.3. Geographical Revenue, 2019
16.1.4. Product Offerings
16.1.5. Recent Initiatives (2017-2019)
16.2. GlaxoSmithKline plc
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Performance (2015-2019)
16.2.3.1. Net Revenue
16.2.3.2. Gross Profit
16.2.3.3. Geographical Revenue, 2019
16.2.4. Product Offerings
16.2.5. Recent Initiatives (2017-2019)
16.3. Pfizer Inc.
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Performance (2015-2019)
16.3.3.1. Net Revenue
16.3.3.2. Gross Profit
16.3.3.3. Geographical Revenue, 2019
16.3.4. Product Offerings
16.3.5. Recent Initiatives (2017-2019)
16.4. Mallinckrodt Plc.
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Performance (2015-2019)
16.4.3.1. Net Revenue
16.4.3.2. Gross Profit
16.4.3.3. Geographical Revenue, 2019
16.4.4. Product Offerings
16.4.5. Recent Initiatives (2017-2019)
16.5. Hikma Pharmaceuticals plc
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Performance (2015-2019)
16.5.3.1. Net Revenue
16.5.3.2. Gross Profit
16.5.3.3. Geographical Revenue, 2019
16.5.4. Product Offerings
16.5.5. Recent Initiatives (2017-2019)
16.6. Orexo AB
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Performance (2015-2019)
16.6.3.1. Net Revenue
16.6.3.2. Gross Profit
16.6.3.3. Geographical Revenue, 2019
16.6.4. Product Offerings
16.6.5. Recent Initiatives (2017-2019)
16.7. Indivior PLC
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Performance (2015-2019)
16.7.3.1. Net Revenue
16.7.3.2. Gross Profit
16.7.3.3. Geographical Revenue, 2019
16.7.4. Product Offerings
16.7.5. Recent Initiatives (2017-2019)
16.8. Hager Biosciences, LLC
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Performance (2015-2019)
16.8.3.1. Net Revenue
16.8.3.2. Gross Profit
16.8.3.3. Geographical Revenue, 2019
16.8.4. Product Offerings
16.8.5. Recent Initiatives (2017-2019)
16.9. ADDEX THERAPEUTICS
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Performance (2015-2019)
16.9.3.1. Net Revenue
16.9.3.2. Gross Profit
16.9.3.3. Geographical Revenue, 2019
16.9.4. Product Offerings
16.9.5. Recent Initiatives (2017-2019)
16.10. Omeros Corporation
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Performance (2015-2019)
16.10.3.1. Net Revenue
16.10.3.2. Gross Profit
16.10.3.3. Geographical Revenue, 2019
16.10.4. Product Offerings
16.10.5. Recent Initiatives (2017-2019)
16.11. Sosei Group Corporation
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financial Performance (2015-2019)
16.11.3.1. Net Revenue
16.11.3.2. Gross Profit
16.11.3.3. Geographical Revenue, 2019
16.11.4. Product Offerings
16.11.5. Recent Initiatives (2017-2019)
16.12. CV Sciences, Inc
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financial Performance (2015-2019)
16.12.3.1. Net Revenue
16.12.3.2. Gross Profit
16.12.3.3. Geographical Revenue, 2019
16.12.4. Product Offerings
16.12.5. Recent Initiatives (2017-2019)
16.13. Astraea Therapeutics LLC
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financial Performance (2015-2019)
16.13.3.1. Net Revenue
16.13.3.2. Gross Profit
16.13.3.3. Geographical Revenue, 2019
16.13.4. Product Offerings
16.13.5. Recent Initiatives (2017-2019)
16.14. Johnson & Johnson Services, Inc.
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financial Performance (2015-2019)
16.14.3.1. Net Revenue
16.14.3.2. Gross Profit
16.14.3.3. Geographical Revenue, 2019
16.14.4. Product Offerings
16.14.5. Recent Initiatives (2017-2019)
16.15. Novartis AG
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financial Performance (2015-2019)
16.15.3.1. Net Revenue
16.15.3.2. Gross Profit
16.15.3.3. Geographical Revenue, 2019
16.15.4. Product Offerings
16.15.5. Recent Initiatives (2017-2019)
16.16. Sanofi
16.16.1. Company Snapshot
16.16.2. Company Overview
16.16.3. Financial Performance (2015-2019)
16.16.3.1. Net Revenue
16.16.3.2. Gross Profit
16.16.3.3. Geographical Revenue, 2019
16.16.4. Product Offerings
16.16.5. Recent Initiatives (2017-2019)
16.17. Dr. Reddy’s Laboratories Ltd
16.17.1. Company Snapshot
16.17.2. Company Overview
16.17.3. Financial Performance (2015-2019)
16.17.3.1. Net Revenue
16.17.3.2. Gross Profit
16.17.3.3. Geographical Revenue, 2019
16.17.4. Product Offerings
16.17.5. Recent Initiatives (2017-2019)
16.18. Teva Pharmaceutical Industries Ltd
16.18.1. Company Snapshot
16.18.2. Company Overview
16.18.3. Financial Performance (2015-2019)
16.18.3.1. Net Revenue
16.18.3.2. Gross Profit
16.18.3.3. Geographical Revenue, 2019
16.18.4. Product Offerings
16.18.5. Recent Initiatives (2017-2019)
16.19. Mylan N.V.
16.19.1. Company Snapshot
16.19.2. Company Overview
16.19.3. Financial Performance (2015-2019)
16.19.3.1. Net Revenue
16.19.3.2. Gross Profit
16.19.3.3. Geographical Revenue, 2019
16.19.4. Product Offerings
16.19.5. Recent Initiatives (2017-2019)
16.20. Axsome Therapeutics, Inc.
16.20.1. Company Snapshot
16.20.2. Company Overview
16.20.3. Financial Performance (2015-2019)
16.20.3.1. Net Revenue
16.20.3.2. Gross Profit
16.20.3.3. Geographical Revenue, 2019
16.20.4. Product Offerings
16.20.5. Recent Initiatives (2017-2019)
16.21. Other Notable Players
17. Conclusion
18. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Addiction Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Addiction Treatment Market Drivers & Restraints 2021
Table 7. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Amplifier Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 54. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 59. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 60. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 61. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 62. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 63. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 64. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 69. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 73. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 74. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 75. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 76. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 77. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 109. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 114. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 119. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 123. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 124. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 125. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 126. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 127. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 129. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 133.
Table 134. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 135. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 136. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 137. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 138. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 139. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 140. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 141. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 142. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 143. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 144. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 145. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 146. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 147. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 148. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 149. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 150. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 151. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 152. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 153. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 154. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 155. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 156. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 157. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 158. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 159. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 160. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 161. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 162. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 163. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 164. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 165. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 166. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 167. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 168. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 169. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 170. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 171. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 172. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 173. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 174. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 175. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 176. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 177. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 178. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 179. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 180. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 181. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 182. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 183. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 184. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 185. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 186. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 187. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 188. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 189. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 190. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 191. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 192. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 193. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 194. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 195. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 196. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 197. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 198. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 199. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 200. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 201. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 202. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 203. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 204. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 205. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 206. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 207. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 208. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 209. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 210. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 211. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 212. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 213. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 214. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 215. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 216. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 217. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 218. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 219. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 220. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 221. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 222. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 223. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 224. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 225. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 226. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 227. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 228. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 229. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 230. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 231. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 232. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 233. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 234. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 235. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 236. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 237. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 238. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 239. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 240. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 241. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 242. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 243. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 244. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 245. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 246. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 247. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 248. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 249. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 250. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 251. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 252. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 253. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 254. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 255. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 256. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 257. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 258. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 259. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 260. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 261. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 262. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 263. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 264. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 265. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 266. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 267. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 268. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 269. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 270. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 271. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 272. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 273. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 274. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 275. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 276. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 277. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 278. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 279. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 280. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 281. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 282. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 283. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 284. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 285. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 286. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 287. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 288. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 289. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 290. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 291. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 292. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 293. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 294. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 295. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 296. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 297. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 298. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 299. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 300. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 301. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 302. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 303. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 304. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 305. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 306. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 307. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 308. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 309. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 310. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 311. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 312. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 313. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 314. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 315. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 316. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 317. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 318. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 319. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 320. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 321. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 322. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 323. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 324. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 325. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 326. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 327. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 328. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 329. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 330. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 331. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 332. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 333. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 334. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 335. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 336. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 337. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 338. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 339. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 340. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 341. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 342. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 343. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 344. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 345. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 346. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 347. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 348. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 349. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 350. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 351. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 352. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 353. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 354. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 355. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 356. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 357. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 358. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 359. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 360. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 361. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 362. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 363. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 364. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 365. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 366. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 367. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 368. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 369. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 370. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 371. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 372. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 373. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 374. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 375. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 376. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 377. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 378. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 379. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 380. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 381. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 382. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 383. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 384. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 385. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 386. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 387. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 388. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 389. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 390. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 391. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 392. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 393. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 394. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 395. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 396. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 397. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 398. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 399. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 400. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 401. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 402. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 403. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 404. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 405. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 406. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 407. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 408. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 409. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 410. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 411. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 412. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 413. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 414. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 415. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 416. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 417. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 418. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 419. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 420. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 421. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 422. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 423. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 424. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 425. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 426. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 427. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 428. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 429. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 430. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 431. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 432. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 433. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 434. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 435. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 436. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 437. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 438. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 439. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 440. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 441. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 442. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 443. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 444. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 445. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 446. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 447. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 448. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 449. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 450. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 451. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 452. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 453. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 454. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 455. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 456. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 457. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 458. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 459. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 460. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 461. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 462. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 463. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 464. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 465. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 466. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 467. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 468. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 469. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 470. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 471. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 472. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 473. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 474. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 475. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 476. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 477. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 478. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 479. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 480. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 481. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 482. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 483. Leading 20 Addiction Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 484. Cipla Ltd.Profile 2019 (CEO, HQ, Founded, Website)
Table 485. Cipla Ltd. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 486. GlaxoSmithKline plc Profile 2019 (CEO, HQ, Founded, Website)
Table 487. GlaxoSmithKline plc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 488. Pfizer Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 489. Mallinckrodt Plc.Addiction Treatment Product Offering (Segment, Product Offerings)
Table 490. Hikma Pharmaceuticals plc Profile 2019 (CEO, HQ, Founded, Website)
Table 491. Hikma Pharmaceuticals plc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 492. Orexo AB Profile 2019 (CEO, HQ, Founded, Website)
Table 493. Orexo AB Addiction Treatment Product Offering (Segment, Product Offerings)
Table 494. Indivior PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 495. Indivior PLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 496. Hager Biosciences, LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 497. Hager Biosciences, LLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 498. ADDEX THERAPEUTICS Profile 2019 (CEO, HQ, Founded, Website)
Table 499. ADDEX THERAPEUTICS Addiction Treatment Product Offering (Segment, Product Offerings)
Table 500. Omeros Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 501. Omeros Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 502. Sosei Group Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 503. Sosei Group Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 504. CV Sciences, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 505. CV Sciences, Inc Addiction Treatment Product Offering (Segment, Product Offerings)
Table 506. Astraea Therapeutics LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 507. Astraea Therapeutics LLC Addiction Treatment Product Offering (Segment, Product Offerings)
Table 508. Johnson & Johnson Services, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 509. Johnson & Johnson Services, Inc. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 510. Novartis AG Profile 2019 (CEO, HQ, Founded, Website)
Table 511. Novartis AG Addiction Treatment Product Offering (Segment, Product Offerings)
Table 512. Sanofi Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 513. Sanofi Corporation Addiction Treatment Product Offering (Segment, Product Offerings)
Table 514. Dr. Reddy’s Laboratories Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 515. Dr. Reddy’s Laboratories Ltd Addiction Treatment Product Offering (Segment, Product Offerings)
Table 516. Teva Pharmaceutical Industries Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 517. Teva Pharmaceutical Industries Ltd Addiction Treatment Product Offering (Segment, Product Offerings)
Table 518. Mylan N.V.Profile 2019 (CEO, HQ, Founded, Website)
Table 519. Mylan N.V.Addiction Treatment Product Offering (Segment, Product Offerings)
Table 520. Axsome Therapeutics, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 521. Axsome Therapeutics, Inc. Addiction Treatment Product Offering (Segment, Product Offerings)
Table 522. Other Companies Involved in the Addiction Treatment Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Addiction Treatment Market Application Overview
Figure 2. Addiction Treatment Market Component Overview
Figure 3. Addiction Treatment Market Treatment Type Overview
Figure 4. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13. Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18. Tobacco/ Nicotine Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23. Alcohol dependence Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28. Marijuana Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33. Synthetic Cannabinoids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 35. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 36. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 37. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 38. Prescription and Over-the-Counter Medications Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 39. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43. Drug abuse Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49. Amplifier Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54. Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 56. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 57. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 58. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 59. Nicotine Replacement Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 60. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 61. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 62. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 63. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 64. Psychological Therapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 65. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 66. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 67. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 68. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 69. Counseling and Behavioral Therapies Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 70. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 71. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 72. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 73. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 74. Rehabilitation programs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 75. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 76. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 77. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 78. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 79. Psychotherapy Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 82. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 83. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 84. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 85. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 86. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 87. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 88. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 89. Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 90. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 91. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 92. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 93. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 94. Approved-Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 95. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 96. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 97. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 98. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 99. Off-label Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 100. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 101. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 102. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 103. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 104. Addiction Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 105. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 106. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 107. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 108. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 109. Patch Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 110. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 111. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 112. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 113. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 114. Gum Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 115. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 116. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 117. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 118. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 119. Pills Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 120. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 121. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 122. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 123. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 124. Lozenge Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 125. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 126. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 127. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 128. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 129. Spray Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 130. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 131. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 132. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 133. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 134. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 135.
Figure 136. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 137. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 138. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 139. Addiction Treatment Market Forecast by Route of Administration Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 140. Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 141. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 142. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 143. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 144. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 145. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 146. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 147. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 148. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 149. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 150. Inhalation Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 151. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 152. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 153. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 154. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 155. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 156. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 157. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 158. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 159. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 160. Addiction Treatment Market Forecast by End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 161. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 162. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 163. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 164. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 165. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 166. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 167. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 168. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 169. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 170. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 171. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 172. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 173. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 174. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 175. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 176. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 177. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 178. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 179. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 180. Rehabilitation treatment centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 181. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 182. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 187. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 192. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 197. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. Retail pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 202. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Ecommerce Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 207. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 212. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 213. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 214. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 215. North America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 216. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 217. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 218. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 219. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 220. North America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 221. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 222. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 223. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 224. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 225. North America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 226. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 227. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 228. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 229. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 230. North America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 231. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 232. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 233. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 234. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 235. North America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 236. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 237. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 238. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 239. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 240. North America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 241. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 242. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 243. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 244. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 245. North America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 246. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 247. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 248. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 249. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 250. North America Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 251. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 252. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 253. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 254. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 255. US Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 256. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 257. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 258. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 259. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 260. Canada Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 261. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID) Table 82.
Figure 262. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 263. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 264. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 265. Europe Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 266. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 267. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 268. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 269. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 270. Europe Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 271. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 272. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 273. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 274. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 275. Europe Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 276. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 277. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 278. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 279. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 280. Europe Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 281. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 282. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 283. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 284. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 285. Europe Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 286. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 287. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 288. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 289. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 290. Europe Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 291. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 292. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 293. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 294. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 295. Europe Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 296. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 297. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 298. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 299. Europe Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 300. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 301. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 302. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 303. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 304. UK Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 305. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 306. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 307. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 308. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 309. Germany Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 310. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 311. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 312. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 313. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 314. France Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 315. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 316. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 317. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 318. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 319. Rest of Europe Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 320. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 321. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 322. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 323. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 324. Asia Pacific Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 325. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 326. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 327. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 328. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 329. Asia Pacific Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 330. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 331. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 332. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 333. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 334. Asia Pacific Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 335. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 336. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 337. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 338. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 339. Asia Pacific Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 340. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 341. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 342. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 343. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 344. Asia Pacific Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 345. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 346. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 347. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 348. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 349. Asia Pacific Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 350. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 351. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 352. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 353. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 354. Asia Pacific Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 355. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 356. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 357. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 358. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 359. Asia Pacific Addiction Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 360. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 361. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 362. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 363. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 364. China Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 365. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 366. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 367. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 368. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 369. India Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 370. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 371. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 372. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 373. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 374. Japan Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 375. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 376. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 377. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 378. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 379. RoAPAC Addiction Treatment Market Forecast 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 380. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 381. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 382. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 383. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 384. Middle East Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 385. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 386. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 387. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 388. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 389. Middle East Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 390. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 391. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 392. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 393. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 394. Middle East Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 395. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 396. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 397. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 398. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 399. Middle East Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 400. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 401. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 402. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 403. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 404. Middle East Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 405. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 406. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 407. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 408. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 409. Middle East Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 410. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 411. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 412. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 413. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 414. Middle East Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 415. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 416. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 417. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 418. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 419. Latin America Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 420. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 421. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 422. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 423. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 424. Latin America Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 425. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 426. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 427. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 428. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 429. Latin America Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 430. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 431. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 432. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 433. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 434. Latin America Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 435. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 436. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 437. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 438. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 439. Latin America Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 440. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 441. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 442. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 443. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 444. Latin America Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 445. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 446. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 447. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 448. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 449. Latin America Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 450. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 451. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 452. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 453. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 454. Africa Addiction Treatment Market Forecast by Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 455. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 456. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 457. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 458. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 459. Africa Addiction Treatment Market Forecast by Treatment Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 460. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 461. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 462. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 463. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 464. Africa Addiction Treatment Market Forecast by Drug Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 465. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 466. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 467. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 468. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 469. Africa Addiction Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 470. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 471. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 472. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 473. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 474. Africa Addiction Treatment Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 475. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 476. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 477. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 478. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 479. Africa Addiction Treatment Market Forecast by End-User 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 480. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (Before COVID)
Figure 481. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario V)
Figure 482. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario U)
Figure 483. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario W)
Figure 484. Africa Addiction Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, ) (COVID - Scenario L)
Figure 485. Porter’s Five Force Analysis
Companies Mentioned
1. Cipla Ltd.
2. GlaxoSmithKline plc
3. Pfizer Inc.
4. Mallinckrodt Plc.
5. Hikma Pharmaceuticals plc
6. Orexo AB
7. Indivior PLC
8. Hager Biosciences, LLC
9. ADDEX THERAPEUTICS
10. Omeros Corporation
11. Sosei Group Corporation
12. CV Sciences, Inc
13. Astraea Therapeutics LLC
14. Johnson & Johnson Services, Inc.
15. Novartis AG
16. Sanofi
17. Dr. Reddy’s Laboratories Ltd
18. Teva Pharmaceutical Industries Ltd
19. Mylan N.V.
20. Axsome Therapeutics, Inc.
21. Hager Biosciences, LLC
22. Axsome Therapeutics, Inc.
23. Cerecor, Inc
24. Axsome Therapeutics, Inc
25. H. Lundbeck A/S
26. Zydus Cadila
27. Glenmark Pharmaceuticals Ltd
28. Alvogen
29. Sigmapharm Laboratories, LLC
30. Bausch Health
31. Currax Pharmaceuticals LLC
32. Alkermes
33. Mallinckrodt plc
34. Teva Pharmaceutical Industries Ltd
35. Pharmaceutical Associates Inc,
36. Reckitt Benckiser (Indivior PLC)
37. Alkermes PLC
38. Allergan, Plc
39. Celtic Pharma Holdings Advisors LLP
40. Cipla Limited
41. Consern Pharma Private Limited
42. Eli Lilly and Company
43. GlaxoSmithKline plc (GSK)
44. Intas Biopharmaceuticals
45. Johnson & Johnson
46. Mallinckrodt Pharmaceuticals
47. Medtronic
48. Novartis International AG
49. Orasure Technologies
50. PSYCHEMEDICS CORPORATION
51. Purdue Pharma L.P.
52. Reckitt Benckiser Group plc
53. Sun Pharmaceutical Industries Limited
54. Takeda Pharmaceutical Company Ltd
55. TEVA PHARMACEUTICALS INDUSTRIES LIMITED
Companies Profiled in the Report
1. Cipla Ltd.
2. GlaxoSmithKline plc
3. Pfizer Inc.
4. Mallinckrodt Plc.
5. Hikma Pharmaceuticals plc
6. Orexo AB
7. Indivior PLC
8. Hager Biosciences, LLC
9. ADDEX THERAPEUTICS
10. Omeros Corporation
11. Sosei Group Corporation
12. CV Sciences, Inc
13. Astraea Therapeutics LLC
14. Johnson & Johnson Services, Inc.
15. Novartis AG
16. Sanofi
17. Dr. Reddy’s Laboratories Ltd
18. Teva Pharmaceutical Industries Ltd
19. Mylan N.V.
20. Axsome Therapeutics, Inc.
List of Companies Mentioned in the Report:
1. Hager Biosciences, LLC
2. Axsome Therapeutics, Inc.
3. Cerecor, Inc
4. Axsome Therapeutics, Inc
5. H. Lundbeck A/S
6. Zydus Cadila
7. Glenmark Pharmaceuticals Ltd
8. Alvogen
9. Sigmapharm Laboratories, LLC
10. Bausch Health
11. Currax Pharmaceuticals LLC
12. Alkermes
13. Mallinckrodt plc
14. Teva Pharmaceutical Industries Ltd
15. Pharmaceutical Associates Inc,
16. Reckitt Benckiser (Indivior PLC)
17. Alkermes PLC
18. Allergan, Plc
19. Celtic Pharma Holdings Advisors LLP
20. Cipla Limited
21. Consern Pharma Private Limited
22. Eli Lilly and Company
23. GlaxoSmithKline plc (GSK)
24. Intas Biopharmaceuticals
25. Johnson & Johnson
26. Mallinckrodt Pharmaceuticals
27. Medtronic
28. Novartis International AG
29. Orasure Technologies
30. PSYCHEMEDICS CORPORATION
31. Purdue Pharma L.P.
32. Reckitt Benckiser Group plc
33. Sun Pharmaceutical Industries Limited
34. Takeda Pharmaceutical Company Ltd
35. TEVA PHARMACEUTICALS INDUSTRIES LIMITED
List of Organizations Mentioned in the Report:
1. Center for Drug Evaluation and Research (CDER)
2. Agência Nacional de Vigilância Sanitária (ANVISA)
3. European Medicines Agency (EMA)
4. Food and Drug Administration (FDA)
5. Ministry of Health, Labour and Welfare (MHLW)
6. Michigan State University
7. National Institute for Health and Clinical Excellence (NICE)
8. National Institutes of Health (NIH)
9. University of Connecticut
10. World Health Organization (WHO)
11. The National Medical Products Administration (NMPA)
12. Indian Council of Medical Research (ICMR)
13. The Therapeutic Goods Administration
14. The Federal Institute for Drugs and Medical Devices (BfArM)
15. Pharmaceuticals and Medical Devices Agency (PMDA)
16. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
17. Ministry of Health, Labour & Welfare(MHLW)
18. Medicines and Healthcare Products Regulatory Agency (MHRA)
19. Centre for Pharmaceutical Administration Health Sciences Authority
20. Central Drug Standard Control Organization (CDSCO)
1. Cipla Ltd.
2. GlaxoSmithKline plc
3. Pfizer Inc.
4. Mallinckrodt Plc.
5. Hikma Pharmaceuticals plc
6. Orexo AB
7. Indivior PLC
8. Hager Biosciences, LLC
9. ADDEX THERAPEUTICS
10. Omeros Corporation
11. Sosei Group Corporation
12. CV Sciences, Inc
13. Astraea Therapeutics LLC
14. Johnson & Johnson Services, Inc.
15. Novartis AG
16. Sanofi
17. Dr. Reddy’s Laboratories Ltd
18. Teva Pharmaceutical Industries Ltd
19. Mylan N.V.
20. Axsome Therapeutics, Inc.
List of Companies Mentioned in the Report:
1. Hager Biosciences, LLC
2. Axsome Therapeutics, Inc.
3. Cerecor, Inc
4. Axsome Therapeutics, Inc
5. H. Lundbeck A/S
6. Zydus Cadila
7. Glenmark Pharmaceuticals Ltd
8. Alvogen
9. Sigmapharm Laboratories, LLC
10. Bausch Health
11. Currax Pharmaceuticals LLC
12. Alkermes
13. Mallinckrodt plc
14. Teva Pharmaceutical Industries Ltd
15. Pharmaceutical Associates Inc,
16. Reckitt Benckiser (Indivior PLC)
17. Alkermes PLC
18. Allergan, Plc
19. Celtic Pharma Holdings Advisors LLP
20. Cipla Limited
21. Consern Pharma Private Limited
22. Eli Lilly and Company
23. GlaxoSmithKline plc (GSK)
24. Intas Biopharmaceuticals
25. Johnson & Johnson
26. Mallinckrodt Pharmaceuticals
27. Medtronic
28. Novartis International AG
29. Orasure Technologies
30. PSYCHEMEDICS CORPORATION
31. Purdue Pharma L.P.
32. Reckitt Benckiser Group plc
33. Sun Pharmaceutical Industries Limited
34. Takeda Pharmaceutical Company Ltd
35. TEVA PHARMACEUTICALS INDUSTRIES LIMITED
List of Organizations Mentioned in the Report:
1. Center for Drug Evaluation and Research (CDER)
2. Agência Nacional de Vigilância Sanitária (ANVISA)
3. European Medicines Agency (EMA)
4. Food and Drug Administration (FDA)
5. Ministry of Health, Labour and Welfare (MHLW)
6. Michigan State University
7. National Institute for Health and Clinical Excellence (NICE)
8. National Institutes of Health (NIH)
9. University of Connecticut
10. World Health Organization (WHO)
11. The National Medical Products Administration (NMPA)
12. Indian Council of Medical Research (ICMR)
13. The Therapeutic Goods Administration
14. The Federal Institute for Drugs and Medical Devices (BfArM)
15. Pharmaceuticals and Medical Devices Agency (PMDA)
16. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
17. Ministry of Health, Labour & Welfare(MHLW)
18. Medicines and Healthcare Products Regulatory Agency (MHRA)
19. Centre for Pharmaceutical Administration Health Sciences Authority
20. Central Drug Standard Control Organization (CDSCO)
Download sample pages
Complete the form below to download your free sample pages for Addiction Treatment Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Addiction Treatment Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
